Published in Thromb Diath Haemorrh on September 30, 1975
The inhibition of plasmin, plasma kallikrein, plasma permeability factor, and the C'1r subcomponent of the first component of complement by serum C'1 esterase inhibitor. J Exp Med (1969) 2.39
Attitudes of patients to clinical teaching. Br J Med Educ (1967) 2.28
Studies on a complex mechanism for the activation of plasminogen by kaolin and by chloroform: the participation of Hageman factor and additional cofactors. J Clin Invest (1969) 2.14
Changing seasonality of birth--a possible environmental effect. J Epidemiol Community Health (1993) 2.09
Changing incidence of Achilles tendon rupture in Scotland: a 15-year study. Clin J Sport Med (1999) 2.07
Adverse effects of large tidal volume and low PEEP in canine acid aspiration. Am Rev Respir Dis (1990) 1.96
Fibrin degradation products in normal and abnormal pregnancy and parturition. Br Med J (1969) 1.92
Modeling the motion of the internal tongue from tagged cine-MRI images. J Acoust Soc Am (2001) 1.78
A method to reconstruct myocardial sarcomere lengths and orientations at transmural sites in beating canine hearts. Am J Physiol (1992) 1.71
Postgraduate medical degrees of the University of Aberdeen, 1931-69. Scott Med J (1970) 1.64
Fibrinolytic enzyme system and pregnancy. Br Med J (1969) 1.63
Plasma fibrinogen and plasminogen levels in health and in ischaemic heart disease. J Clin Pathol (1966) 1.55
Venous thrombosis following strokes. Lancet (1972) 1.46
Familial thrombosis: inherited deficiency of antithrombin III. Br Med J (1978) 1.40
Coagulation and fibrinolytic systems in pre-eclampsia and eclampsia. Br Med J (1971) 1.39
Malaria acquired in Bali. Med J Aust (1995) 1.37
The molded polythene splint for mallet finger deformities. J Hand Surg Am (1984) 1.30
Modeling tongue surface contours from Cine-MRI images. J Speech Lang Hear Res (2001) 1.27
Studies on the blood fibrinolytic enzyme system following acute myocardial infarction. Clin Sci (1967) 1.26
Coagulation and fibrinolytic mechanisms during and after normal childbirth. Br Med J (1970) 1.21
Further medical education of Aberdeen graduates 1956-58. Br J Med Educ (1969) 1.18
Deep venous thrombosis of the legs after strokes. Part I--incidence and predisposing factors. Br Med J (1976) 1.15
The effect on dipyridamole on platelet aggregation and adhesiveness. Scott Med J (1968) 1.14
Diagnosis of deep vein thrombosis using autologous indium-III-labelled platelets. Br Med J (Clin Res Ed) (1981) 1.12
The assay of a plasma component necessary for the generation of a plasminogen activator in the presence of Hageman factor (Hageman factor co-factor). Br J Haematol (1971) 1.12
A double-blind trial of low doses of subcutaneous heparin in the prevention of deep-vein thrombosis after myocardial infarction. Lancet (1973) 1.11
Serum Mucoproteins and Plasma Fibrinolytic Activity in Coronary-artery Disease. Br Med J (1962) 1.10
The relationship between platelet aggregation and time interval after venepuncture. Thromb Diath Haemorrh (1974) 1.08
Disseminated intravascular coagulation: a review. J Clin Pathol (1978) 1.07
Plasminogen-activator-producing tumour. Br Med J (1969) 1.07
Present employment of University of Aberdeen medical graduates, 1956-58. Lancet (1969) 1.06
Indium-111 labelled platelets in diagnosis of leg-vein thrombosis: preliminary findings. Br Med J (1980) 1.02
Individualisation of oral anticoagulant therapy. Drugs (1979) 1.00
Renal complications in haemophilia and Christmas disease. Q J Med (1971) 0.98
Tranexamic acid in control of haemorrhage after dental extraction in haemophilia and Christmas disease. Br Med J (1972) 0.98
The inhibition of urokinase by alpha 2 -macroglobulin. Clin Sci (1973) 0.97
Effects on blood coagulation, fibrinolysis, and platelet aggregation of normal and atheronatous aortic tissue. J Clin Pathol (1966) 0.97
Oral anticoagulants. Clin Haematol (1981) 0.97
Platelet abnormality in human scurvy. Lancet (1967) 0.96
The plasminogen content of thrombi. Thromb Diath Haemorrh (1966) 0.96
Effect in vitro on platelet function of two compounds developed from the pyrimido-pyrimidines. J Clin Pathol (1972) 0.96
Seasonal variation in deep vein thrombosis. Fatal pulmonary embolism is increased in both autumn and winter. BMJ (1996) 0.95
Familial antithrombin III deficiency. Q J Med (1982) 0.95
Haemostatic mechanism in the uterine circulation during placental separation. Br Med J (1970) 0.95
Studies on the fibrinolytic enzyme system in obesity. J Clin Pathol (1966) 0.94
In vitro and in vivo studies with trasylol, an anticoagulant and a fibrinolytic inhibitor. Br J Haematol (1968) 0.94
Raised plasma oestradiol and oestrone levels in young survivors of myocardial infarction. Lancet (1978) 0.93
The metabolism of Plasmodium berghei, the malaria parasite of rodents. 2. An effect of mepacrine on the metabolism of glucose by the parasite separated from its host cell. Biochem J (1961) 0.93
Evaluation of diagnostic significance of certain symptoms and physical signs in anaemic patients. Br Med J (1969) 0.92
Inhibitors of the fibrinolytic enzyme system in renal disease. Clin Sci (1970) 0.92
Effect of oestriol on platelet adhesiveness and fibrinolysis in men. Lancet (1966) 0.91
Psychogenic purpura. Br Med J (1971) 0.91
Effect of exercise on platelet count, adhesion, and aggregation. Acta Haematol (1974) 0.91
Amyloidosis associated with the nephrotic syndrome and transfusion reactions in a haemophiliac. Br J Haematol (1971) 0.90
High incidence of myelomatosis in North-East Scotland. Scott Med J (1973) 0.90
Varicella zoster antibody testing in the care of pregnant women exposed to varicella. Am J Obstet Gynecol (1987) 0.90
Deep venous thrombosis of the legs after strokes: Part 2-Natural history. Br Med J (1976) 0.90
Platelet adhesiveness, coagulation, and fibrinolytic activity in obesity. J Clin Pathol (1972) 0.90
Factors influencing the prognosis in myelomatosis. Postgrad Med J (1971) 0.90
Sequential studies on components of the haemostatic mechanism in pregnancy with particular reference to the development of pre-eclampsia. Br J Obstet Gynaecol (1976) 0.90
Aggregation of human platelets by commercial preparations of bovine and porcine antihaemophilic globulin. J Clin Pathol (1972) 0.89
Screw fixation for certain fractures of the phalanges and metacarpals. J Bone Joint Surg Am (1976) 0.89
'Persantin'-aspirin reinfarction study. Lancet (1976) 0.89
Gastrointestinal bleeding in haemophilia. Q J Med (1973) 0.88
Methotrexate and the platelet count. Br J Cancer (1968) 0.88
The inhibition of tissue activator and urokinase by human plasma. Thromb Haemost (1982) 0.88
The blood coagulation and fibrinolytic systems in the newborn and the mother at birth. J Obstet Gynaecol Br Commonw (1971) 0.87
Surface-mediated reactions in the formation of thrombin, plasmin and kallikrein. Br Med Bull (1978) 0.87
Relationships between platelet function tests in normal and uraemic subjects. J Clin Pathol (1970) 0.87
Coagulation and fibrinolysis in thyroid disease. Acta Haematol (1978) 0.87
Malaria: a new facet of heroin addiction in Australia. Med J Aust (1978) 0.86
The inhibition by plasma of urokinase and tissue activator-induced fibrinolysis in pregnancy and the puerperium. Thromb Haemost (1983) 0.86
The effect of fat feeding on fibrinolysis, "Stypven" time and platelet aggregation. J Atheroscler Res (1967) 0.86
The fibrinolytic enzyme system in hepatic cirrhosis and malignant metastases. J Clin Pathol (1971) 0.86
Frequency of venous thrombosis in patients with an exacerbation of chronic obstructive lung disease. Thorax (1983) 0.85
Seasonal changes in psychological well-being in an elderly population. Br J Psychiatry (1997) 0.85
Surface ordering transitions at a liquid crystal-solid interface above the isotropic smectic-A transition. Phys Rev Lett (2003) 0.85
Studies on an inhibitor of plasminogen activators in human platelets. Br J Haematol (1974) 0.85
Rotatory subluxation of the scaphoid after excision of dorsal carpal ganglion and wrist manipulation--a case report. J Hand Surg Am (1983) 0.85
Arcus senilis and coronary artery disease. Am Heart J (1965) 0.85
Cell numbers and in vitro responses of leucocytes and lymphocyte subpopulations following maximal exercise and interval training sessions of different intensities. Eur J Appl Physiol Occup Physiol (1992) 0.85
Decreased axial and peripheral bone density in patients taking long-term warfarin. QJM (1995) 0.84
The contribution of plasma protease inhibitors to antiplasmin activity in man. Clin Sci Mol Med (1976) 0.84
Action of a pyrimido-pyrimidine compound on platelet behaviour in vitro. Br Med J (1969) 0.84
Inhibitors of plasminogen activation in human blood. Br J Haematol (1976) 0.83
Epsilon-aminocaproic acid therapy in ulcerative colitis. Am J Dig Dis (1973) 0.83
Plasminogen activation and the coagulation process. J Clin Pathol (1969) 0.83